American Portfolios Advisors Verastem, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Verastem, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,985 shares of VSTM stock, worth $11,820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,985Holding current value
$11,820% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VSTM
# of Institutions
5Shares Held
297KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY225KShares$891,0000.14% of portfolio
-
Beaumont Financial Partners, LLC48KShares$190,0800.0% of portfolio
-
Eaton Vance Management Boston, MA20KShares$79,2000.0% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L21.07KShares$4,2530.0% of portfolio
About Verastem, Inc.
- Ticker VSTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 210,000,000
- Market Cap $832M
- Description
- Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...